Anna Richo Joins Illumina's Board of Directors
Anna Richo Joins Illumina's Board of Directors
Ms. Richo brings more than 30 years of global legal, compliance, and regulatory experience to Illumina's Board
Richo 女士拥有超过 30 年的全球法律、合规和监管经验 致Illumina董事会
SAN DIEGO, May 20, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that Anna Richo has joined the company's Board of Directors following shareholder approval of the director slate at the company's May 16, 2024, annual meeting. Ms. Richo currently serves as Corporate Senior Vice President, Strategic Advisor to the General Counsel and CEO at Cargill, Inc. a global food production and agricultural company.
圣地亚哥，2024年5月20日 /PRNewswire/ — Illumina, Inc.（纳斯达克股票代码：ILMN）今天宣布，在公司2024年5月16日的年会上股东批准董事名单后，安娜·里乔已加入公司董事会。Richo 女士目前担任全球食品生产和农业公司嘉吉公司的企业高级副总裁、总法律顾问兼首席执行官的战略顾问。
Ms. Richo brings more than 30 years of regulated-industry experience as an attorney and legal executive, with extensive experience in compliance and business ethics, intellectual property, and corporate litigation. She formerly served as Corporate Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary at Cargill, where she oversaw the company's corporate governance, global ethics and compliance, global security, global government relations, law, and shareholder relations functions.
Richo女士拥有超过30年的受监管行业从业经历，担任律师和法律主管，在合规和商业道德、知识产权和公司诉讼方面拥有丰富的经验。她曾在嘉吉担任公司高级副总裁、总法律顾问、首席合规官和公司秘书，负责监督公司的公司治理、全球道德与合规、全球安全、全球政府关系、法律和股东关系职能。
Prior to joining Cargill, Ms. Richo was Executive Vice President and General Counsel at UCB, a biopharmaceutical company based in Belgium. She also served as Senior Vice President and Chief Compliance Officer at Amgen, a global biotechnology company, and as Chief Litigation Counsel, Associate General Counsel, and Vice President of Law at Baxter Healthcare.
在加入嘉吉之前，Richo 女士曾在总部位于比利时的生物制药公司 UCB 担任执行副总裁兼总法律顾问。她还曾在全球生物技术公司安进担任高级副总裁兼首席合规官，并在百特医疗担任首席诉讼顾问、副总法律顾问和法律副总裁。
"I am thrilled to welcome Anna to our Board of Directors," said Jacob Thaysen, CEO of Illumina. "In today's evolving business and regulatory environment, her extensive global legal, compliance, and regulatory experience, including at biotechnology, biopharmaceutical, and medtech companies, will enhance our evaluation and understanding of the risks and opportunities associated with Illumina's expanding worldwide operations."
Illumina首席执行官雅各布·塞森说：“我很高兴欢迎安娜加入我们的董事会。”“在当今不断变化的商业和监管环境中，她丰富的全球法律、合规和监管经验，包括在生物技术、生物制药和医疗技术公司的经验，将增强我们对与Illumina全球业务扩张相关的风险和机遇的评估和理解。”
Ms. Richo also serves as a member of Exelon's Board of Directors, as a member of the Cargill Foundation Board of Directors, on the Board of Trustees for DePaul University, and on the Children's Minnesota Governance Board.
Richo 女士还担任 Exelon 董事会成员、嘉吉基金会董事会成员、德保罗大学董事会成员和明尼苏达州儿童组织管理委员会成员。
Ms. Richo holds a B.S. in Industrial and Labor Relations from Cornell University and a J.D. from DePaul University College of Law.
Richo 女士拥有康奈尔大学劳资关系学士学位和德保罗大学法学院法学博士学位。
About Illumina
关于 Ilumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X(Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube.
Investors:
Salli Schwartz
858-291-6421
IR@illumina.com
投资者：
Salli Schwartz
858-291-6421
IR@illumina.com
Media:
Bonny Fowler
740-641-5579
PR@illumina.com
媒体：
邦尼·福勒
740-641-5579
PR@illumina.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/anna-richo-joins-illuminas-board-of-directors-302150329.html
SOURCE Illumina, Inc.
来源 Illumina, Inc.